Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies

被引:170
作者
Fusar-Poli, Paolo [1 ]
Meyer-Lindenberg, Andreas [2 ]
机构
[1] Univ Pavia, Dept Hlth Sci, Sect Psychiat, I-27100 Pavia, Italy
[2] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, D-6800 Mannheim, Germany
关键词
neuroimaging; PET; striatum; dopamine; schizophrenia; psychosis; antipsychotic; POSITRON-EMISSION-TOMOGRAPHY; SYNTHESIS CAPACITY; PREFRONTAL CORTEX; PRODROMAL SIGNS; BRAIN; PSYCHOSIS; RELEASE; NAIVE; DYSFUNCTION; PREDICTION;
D O I
10.1093/schbul/sbr180
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Alterations in striatal dopamine neurotransmission are central to the emergence of psychotic symptoms and to the mechanism of action of antipsychotics. Although the functional integrity of the presynaptic system can be assessed by measuring striatal dopamine synthesis capacity (DSC), no quantitative meta-analysis is available. Methods: Eleven striatal (caudate and putamen) [C-11/F-18]-DOPA positron emission tomography studies comparing 113 patients with schizophrenia and 131 healthy controls were included in a quantitative meta-analysis of DSC. Demographic, clinical, and methodological variables were extracted from each study or obtained from the authors and tested as covariates. Hedges' g was used as a measure of effect size in Comprehensive Meta-Analysis. Publication bias was assessed with funnel plots and Egger's intercept. Heterogeneity was addressed with the Q statistic and I-2 index. Results: Patients and controls were well matched in sociodemographic variables (P > .05). Quantitative evaluation of publication bias was nonsignificant (P = .276). Heterogeneity across study was modest in magnitude and statistically nonsignificant (Q = 19.19; P = .078; I-2 = 39.17). Patients with schizophrenia showed increased striatal DSC as compared with controls (Hedges' g = 0.867, CI 95% from 0.594 to 1.140, Z = 6.222, P < .001). The DSC schizophrenia/control ratio showed a relatively homogenous elevation of around 14% in schizophrenic patients as compared with controls. DSC elevation was regionally confirmed in both caudate and putamen. Controlling for potential confounders such as age, illness duration, gender, psychotic symptoms, and exposure to antipsychotics had no impact on the results. Sensitivity analysis confirmed robustness of meta-analytic findings. Conclusions: The present meta-analysis showed consistently increased striatal DSC in schizophrenia, with a 14% elevation in patients as compared with healthy controls.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 56 条
[1]   What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update [J].
Abbott, C ;
Bustillo, J .
CURRENT OPINION IN PSYCHIATRY, 2006, 19 (02) :135-139
[2]  
Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761
[3]   Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients [J].
Anand, A ;
Verhoeff, P ;
Seneca, N ;
Zoghbi, SS ;
Seibyl, JP ;
Charney, DS ;
Innis, RB .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (07) :1108-1114
[4]  
[Anonymous], ARCH GEN PS IN PRESS
[5]  
[Anonymous], 1983, Journal of Educational Statistics, DOI [DOI 10.2307/1164923, DOI 10.3102/1076998600800215]
[6]  
Borenstein M., 2013, BIOSTAT
[7]   The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia? [J].
Borgwardt, S. J. ;
Smieskova, R. ;
Fusar-Poli, P. ;
Bendfeldt, K. ;
Riecher-Roessler, A. .
PSYCHOLOGICAL MEDICINE, 2009, 39 (11) :1781-1782
[8]   Relationship of Striatal Dopamine Synthesis Capacity to Age and Cognition [J].
Braskie, Meredith N. ;
Wilcox, Claire E. ;
Landau, Susan M. ;
O'Neil, James P. ;
Baker, Suzanne L. ;
Madison, Cindee M. ;
Kluth, Jennifer T. ;
Jagust, William J. .
JOURNAL OF NEUROSCIENCE, 2008, 28 (52) :14320-14328
[9]   Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence [J].
Carlsson, A ;
Waters, N ;
Holm-Waters, S ;
Tedroff, J ;
Nilsson, M ;
Carlsson, ML .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :237-260
[10]   Presynaptic dopaminergic function in the striatum of schizophrenic patients [J].
DaoCastellana, MH ;
PaillereMartinot, ML ;
Hantraye, P ;
AttarLevy, D ;
Remy, P ;
Crouzel, C ;
Artiges, E ;
Feline, A ;
Syrota, A ;
Martinot, JL .
SCHIZOPHRENIA RESEARCH, 1997, 23 (02) :167-174